JAGSNPHARM
Invest with MTF
Invest Now
Invest in Jagsonpal Pharmaceuticals with 2.2X leverage
Performance
- Low
- ₹173
- High
- ₹177
- 52 Week Low
- ₹155
- 52 Week High
- ₹302
- Open Price₹177
- Previous Close₹179
- Volume9,939
- 50 DMA₹185.07
- 100 DMA₹198.19
- 200 DMA₹208.50
Investment Returns
- Over 1 Month -2.26%
- Over 3 Month -18.27%
- Over 6 Month -29.42%
- Over 1 Year -27.63%
Smart Investing Starts Here Start SIP with Jagsonpal Pharmaceuticals for Steady Growth!
Jagsonpal Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 28.6
- PEG Ratio
- -1.3
- Market Cap Cr
- 1,170
- P/B Ratio
- 4.6
- Average True Range
- 7.46
- EPS
- 6.37
- Dividend Yield
- 1.4
- MACD Signal
- -4.26
- RSI
- 51.22
- MFI
- 44.64
Jagsonpal Pharmaceuticals Financials
Jagsonpal Pharmaceuticals Technicals
EMA & SMA
Current Price
₹174.86
-4
(-2.24%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹176.07
- 50 Day
- ₹185.07
- 100 Day
- ₹198.19
- 200 Day
- ₹208.50
Resistance and Support
179.85
- R3 189.67
- R2 186.73
- R1 182.79
- S1 175.91
- S2 172.97
- S3 169.03
Jagsonpal Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Jagsonpal Pharmaceuticals F&O
About Jagsonpal Pharmaceuticals
- NSE Symbol
- JAGSNPHARM
- BSE Symbol
- 507789
- Managing Director
- Mr. Manish Gupta
- ISIN
- INE048B01035
Similar Stocks to Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals FAQs
Jagsonpal Pharmaceuticals share price is ₹174 As on 13 February, 2026 | 11:43
The Market Cap of Jagsonpal Pharmaceuticals is ₹1169.6 Cr As on 13 February, 2026 | 11:43
The P/E ratio of Jagsonpal Pharmaceuticals is 28.6 As on 13 February, 2026 | 11:43
The PB ratio of Jagsonpal Pharmaceuticals is 4.6 As on 13 February, 2026 | 11:43
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.